FDA Cites Teva Supplier Celltrion in Follow-Up Inspection

Drug Industry Daily
A A
A Celltrion plant based in Incheon City, South Korea, was hit again by the FDA for violations observed during an inspection last month following a February warning letter.

To View This Article:

Login

Subscribe To Drug Industry Daily